1 Nussberger J. Ceterum censeo – Reninhemmer zur Hypertoniebehandlung. Swiss Med Forum. 2023;23(17):1037.
2 Messerli FH, Siontis GCM, Rexhaj E. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations. Circulation. 2020;141(25):2042–4.
3 Oh BH, Mitchell J, Herron JR, Chung J, Khan M, Keefe DL. Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension. J Am Coll Cardiol 2007;49:1157–63.
4 Musini VM, Lawrence KA, Fortin PM, Bassett K, Wright JM. Blood pressure lowering efficacy of renin inhibitors for primary hypertension. Cochrane Database Syst Rev. 2017 Apr 5;4(4):CD007066.
5 Neagoe MA, Holzknecht A, Messerli FH. Quo usque tandem – wie lange noch? Swiss Med Forum. 2022;22(41):678–80.